A new expert consensus decision pathway published by the American College of Cardiology highlights the importance of recognizing and diagnosing cardiac amyloidosis at an early stage to allow the most ...

Amyloid heart disease is under-recognized. Early detection and prompt initiation of therapy are critically important. With advances in imaging technology, the diagnosis or surveillance of cardiac ...

Please provide your email address to receive an email when new articles are posted on . The incidence of cardiac amyloidosis in the Danish population increased in the last 2 decades, translating to a ...

The American College of Cardiology (ACC) has issued an expert consensus decision pathway highlighting the importance of recognizing and diagnosing cardiac amyloidosis early to allow the most favorable ...

Novel directed therapies for transthyretin cardiac amyloidosis (ATTR) have been shown to improve outcomes and reduce the long-term negative effects of unchecked amyloid proliferation in patients with ...

FRANKFORD (WPVI) -- Heart failure often follows heart attacks, diabetes, or high blood pressure. However, a very different cause is being identified more and more. For Elsie McGruder, the first sign ...

Cardiac amyloidosis is a serious disease in which abnormal proteins (amyloids) accumulate in the heart muscle and impair heart function. As the disease leads to serious complications such as heart ...

AI algorithm has achieved remarkable accuracy in detecting cardiac amyloidosis, outperforming traditional diagnostic methods.

Researchers at Boston Medical Center (BMC) and Boston University School of Medicine (BUSM), in collaboration with Columbia University Irving Medical Center (CUIMC), are leading a national, multi-site ...

A month after raising $55 million to advance its AI-enhanced ultrasound diagnostics for cardiovascular disease, Ultromics Ltd. presented strong results for its U.S. FDA-cleared AI analysis of ...

DEAR MAYO CLINIC: My dad was diagnosed with cardiac amyloidosis shortly after his 70th birthday. It's difficult to pronounce let alone understand. What is cardiac amyloidosis? Am I at risk if it is ...

The heart-focused artificial intelligence company Anumana is looking to break new ground for its algorithms through a partnership with Pfizer. They plan to develop programs that can help diagnose ...